Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...
Historically, osteochondral lesions of the talus were treated with debridement with or without bone marrow stimulation ...
Vinmec Healthcare System is emerging as a regional leader in advanced medicine, combining robotic surgery, AI-driven ...
A man known as the "Oslo patient" joins a list of people in long-term remission from HIV following bone marrow transplants.
HAE is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of HAE shares has increased $1.21 since the market last closed. This is a 2.04% ...